AGF Investments America’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-105,309
| Closed | -$844K | – | 70 |
|
|
2021
Q4 | $844K | Buy |
105,309
+2,506
| +2% | +$22.6K | 0.16% | 59 |
|
|
2021
Q3 | $1M | Hold |
102,803
| – | – | 0.21% | 60 |
|
|
2021
Q2 | $1.02M | Buy |
102,803
+2,187
| +2% | +$23.1K | 0.24% | 60 |
|
|
2021
Q1 | $1.16M | Hold |
100,616
| – | – | 0.29% | 61 |
|
|
2020
Q4 | $971K | Buy |
100,616
+94
| +0.1% | +$901 | 0.25% | 64 |
|
|
2020
Q3 | $906K | Buy |
100,522
+1,219
| +1% | +$12.9K | 0.27% | 59 |
|
|
2020
Q2 | $1.22M | Buy |
99,303
+3,357
| +3% | +$38K | 0.42% | 51 |
|
|
2020
Q1 | $862K | Buy |
95,946
+1,370
| +1% | +$14K | 0.36% | 55 |
|
|
2019
Q4 | $927K | Buy |
94,576
+837
| +0.9% | +$7.47K | 0.31% | 53 |
|
|
2019
Q3 | $645K | Buy |
93,739
+1,842
| +2% | +$14.1K | 0.21% | 58 |
|
|
2019
Q2 | $848K | Buy |
91,897
+1,672
| +2% | +$20.2K | 0.29% | 55 |
|
|
2019
Q1 | $1.42M | Buy |
90,225
+29,904
| +50% | +$527K | 0.5% | 52 |
|
|
2018
Q4 | $930K | Buy |
60,321
+1,458
| +2% | +$29.9K | 0.38% | 56 |
|
|
2018
Q3 | $1.27M | Buy |
58,863
+19,361
| +49% | +$449K | 0.44% | 55 |
|
|
2018
Q2 | $961K | Buy |
39,502
+916
| +2% | +$18.7K | 0.35% | 59 |
|
|
2018
Q1 | $659K | Buy |
38,586
+707
| +2% | +$13.8K | 0.25% | 64 |
|
|
2017
Q4 | $718K | Buy |
37,879
+1,023
| +3% | +$15.4K | 0.27% | 62 |
|
|
2017
Q3 | $649K | Buy |
36,856
+454
| +1% | +$10.2K | 0.25% | 63 |
|
|
2017
Q2 | $1.21M | Buy |
36,402
+12,748
| +54% | +$395K | 0.47% | 56 |
|
|
2017
Q1 | $759K | Buy |
23,654
+425
| +2% | +$14.5K | 0.31% | 62 |
|
|
2016
Q4 | $842K | Buy |
23,229
+282
| +1% | +$11.3K | 0.36% | 62 |
|
|
2016
Q3 | $1.06M | Buy |
22,947
+82
| +0.4% | +$4.28K | 0.46% | 59 |
|
|
2016
Q2 | $1.15M | Buy |
+22,865
| New | +$1.22M | 0.52% | 57 |
|
|
2016
Q1 | – | Sell |
-9,179
| Closed | -$603K | – | 37 |
|
|
2015
Q4 | $603K | Sell |
9,179
-43,965
| -83% | -$2.72M | 0.44% | 33 |
|
|
2015
Q3 | $3M | Sell |
53,144
-4,077
| -7% | -$264K | 1.9% | 24 |
|
|
2015
Q2 | $3.38M | Buy |
57,221
+600
| +1% | +$37K | 1.7% | 27 |
|
|
2015
Q1 | $3.53M | Sell |
56,621
-3
| -0% | -$174 | 1.68% | 28 |
|
|
2014
Q4 | $3.26M | Sell |
56,624
-77,491
| -58% | -$4.32M | 1.63% | 29 |
|
|
2014
Q3 | $7.21M | Sell |
134,115
-1,653
| -1% | -$87.6K | 2.79% | 17 |
|
|
2014
Q2 | $7.12M | Sell |
135,768
-12,300
| -8% | -$629K | 2.76% | 16 |
|
|
2014
Q1 | $7.82M | Sell |
148,068
-222,685
| -60% | -$10.3M | 3.04% | 16 |
|
|
2013
Q4 | $14.9M | Sell |
370,753
-5,600
| -1% | -$221K | 5.14% | 4 |
|
|
2013
Q3 | $14.2M | Sell |
376,353
-43,800
| -10% | -$1.71M | 5.01% | 5 |
|
|
2013
Q2 | $16.5M | Buy |
+420,153
| New | +$16.4M | 5.74% | 5 |
|
Other funds holding TEVA
ACM
MMH
MIFH
CI
PF
HIIFS
AGF Investments America's TEVA Position: Q1 2022 in Review
AGF Investments America sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q1 2022, closing a stake of 105,309 shares — an estimated $844K sold.
AGF Investments America first reported a position in TEVA in Q2 2013 and held it in 34 quarters. The position peaked at $16.5M in Q2 2013. 438 funds tracked by Wall St. Rank hold TEVA as of Q1 2022.
- AGF Investments America reported no remaining Teva Pharmaceutical Industries Limited position as of Q1 2022 after selling out during the quarter.
- AGF Investments America sold 105,309 Teva Pharmaceutical Industries Limited shares in Q1 2022, an estimated $844K.
- AGF Investments America first reported a position in Teva Pharmaceutical Industries Limited in Q2 2013 and held it in 34 quarters.
- AGF Investments America's Teva Pharmaceutical Industries Limited position peaked at $16.5M in Q2 2013.
- 438 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q1 2022.
Based on AGF Investments America's 13F filing for Q1 2022, filed 10 May 2022.